Abstract
A high-molecular-weight alkali-labile polysaccharide (PS) isolated from the slime of immunotype 1 Pseudomonas aeruginosa was tested for its ability to protect mice from lethal challenge with the live, homologous organism. Intraperitoneal (i.p.) injection of 10 to 25 microgram of the PS protected 60 to 70% of the mice against challenge with up to 50 50% lethal dose units. Although single immunization of mice with up to 250 microgram of PS effected protective levels of only 70%, two successive immunizations provided 100% protection. Subcutaneous and intravenous immunization with PS also provided protection to i.p. challenges with immunotype 1 P. aeruginosa, but not to i.p. challenge with immunotype 4 P. aeruginosa. Although lipopolysaccharide (LPS) was found to be more immunogenic than PS in out studies, contamination of the alkali-labile PS with LPS did not account for the protection seen. Alkali treatment (0.1 N NaOH, 37 degrees C, 2 h) of the PS destroyed its protective effectiveness, while similarly treated LPS retained its capacity for inducing immunity in mice. Adsorption and passive protection studies with sera raised to either PS or a mixture of PS and LPS indicated that antibody directed to the alkali-labile PS antigen was capable of contributing to the protection of mice against challenge with P. aeruginosa.
MeSH Terms
Animals
Antibodies, Bacterial/biosynthesis,immunology
Antigens, Bacterial
Immunity, Active
Immunization, Passive
Mice
Mice, Inbred ICR
Polysaccharides, Bacterial/immunology
Pseudomonas Infections/immunology
Pseudomonas aeruginosa/immunology
Chemicals
Antibodies, Bacterial
Antigens, Bacterial
Polysaccharides, Bacterial
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Pier G B
Sidberry H F
Sadoff J C
References (22)
22 references, click to expand
-
Prevention of pneumococcal infection by immunization with capsular polysaccharides of Streptococcus pneumoniae: current status of polyvalent vaccines.
J Infect Dis. 1977 Aug;136 Suppl:S38-42
PMID: 19543
-
A Clinical Lecture ON A CASE OF BACILLUS PYOCYANEUS PYAEMIA SUCCESSFULLY TREATED BY VACCINE: Delivered at the Bristol General Hospital.
Br Med J. 1909 May 15;1(2524):1169-70
PMID: 20764470
-
Isolation and characterization of a high-molecular-weight polysaccharide from the slime of Pseudomonas aeruginosa.
Infect Immun. 1978 Dec;22(3):908-18
PMID: 103840
-
A new polyvalent Pseudomonas vaccine.
J Med Microbiol. 1977 Feb;10(1):19-27
PMID: 402473
-
Direct evidence for the presence of lipopolysaccharide components in Pseudomonas ribosomal vaccine.
Infect Immun. 1977 Aug;17(2):471-3
PMID: 408275
-
Analysis of parameters affecting the solid phase radioimmunoassay quantitation of antibody to meningococcal antigens.
J Immunol. 1976 Nov;117(5 Pt.2):1788-98
PMID: 825573
-
Infections caused by Pseudomonas species in patients with burns and in other surgical patients.
J Infect Dis. 1974 Nov;130 Suppl(0):S8-13
PMID: 4138183
-
Pseudomonas aeruginosa vaccine in cancer patients.
Ann Intern Med. 1973 Oct;79(4):518-27
PMID: 4201225
-
Nosocomial infections due to Pseudomonas.
J Infect Dis. 1974 Nov;130 Suppl(0):S4-7
PMID: 4213715
-
Bacteremia due to Pseudomonas aeruginosa complicating neoplastic disease: a progress report.
J Infect Dis. 1974 Nov;130 Suppl(0):S14-23
PMID: 4213872
-
Significance of Pseudomonas aeruginosa in the patient with leukemia or lymphoma.
J Infect Dis. 1974 Nov;130 Suppl(0):S24-31
PMID: 4213977
-
Specificity of the protective response induced by the slime layer of Pseudomonas aeruginosa.
J Hyg (Lond). 1974 Aug;73(1):75-84
PMID: 4213979
-
Preliminary investigations of Pseudomonas aeruginosa vaccine in patients with leukemia and cystic fibrosis.
J Infect Dis. 1974 Nov;130 Suppl(0):S159-62
PMID: 4213986
-
Pseudomonas aeruginosa infections.
CRC Crit Rev Clin Lab Sci. 1972 Sep;3(3):291-347
PMID: 4376736
-
Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b.
Pediatrics. 1973 Nov;52(5):637-44
PMID: 4542777
-
The effect of ethylenediaminetetra-acetic acid on the cell walls of some gram-negative bacteria.
J Gen Microbiol. 1965 Jun;39(3):385-99
PMID: 4955831
-
Studies on the isolation of an infection-protective antigen from Psudomonas aeruginosa.
Surg Gynecol Obstet. 1966 Nov;123(5):965-77
PMID: 4959020
-
Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state.
J Exp Med. 1969 Jun 1;129(6):1385-95
PMID: 4977284
-
Prevention of invasive pseudomonas infection in burns with a new vaccine.
Arch Surg. 1969 Aug;99(2):249-56
PMID: 4978523
-
Isolation and characterization of antigenic components of a new heptavalent Pseudomonas vaccine.
Nat New Biol. 1971 Feb 17;229(7):209-10
PMID: 5281014
-
Susceptibility of burned mice to Pseudomonas aeruginosa and protection by vaccination.
Ann Surg. 1966 Apr;163(4):603-10
PMID: 5934635
-
Outer-membrane protein and lipopolysaccharide serotyping of Neisseria meningitidis by inhibition of a solid-phase radioimmunoassay.
Infect Immun. 1977 Nov;18(2):424-33
PMID: 72735